QIX Deutschland
|
17 477,43
|
-10,16
|
-0,06 %
|
Analysen zu QIX Deutschland-Werten
| 19.12.25 | Siemens Healthineers Buy | Jefferies & Company Inc. | |
| 19.12.25 | DHL Group Equal Weight | Barclays Capital | |
| 18.12.25 | Henkel vz. Market-Perform | Bernstein Research | |
| 18.12.25 | DHL Group Market-Perform | Bernstein Research | |
| 18.12.25 | Siemens Healthineers Overweight | Barclays Capital | |
| 18.12.25 | Brenntag Buy | Warburg Research | |
| 18.12.25 | RATIONAL Buy | UBS AG | |
| 18.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 17.12.25 | Henkel vz. Market-Perform | Bernstein Research | |
| 17.12.25 | Hannover Rück Buy | UBS AG | |
| 17.12.25 | Sartorius vz. Buy | Deutsche Bank AG | |
| 17.12.25 | Carl Zeiss Meditec Buy | Goldman Sachs Group Inc. | |
| 17.12.25 | Nemetschek Hold | Deutsche Bank AG | |
| 17.12.25 | Siemens Healthineers Outperform | RBC Capital Markets | |
| 16.12.25 | Sartorius vz. Outperform | Bernstein Research | |
| 16.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 16.12.25 | Gerresheimer Underperform | Bernstein Research | |
| 16.12.25 | Siemens Healthineers Outperform | Bernstein Research | |
| 16.12.25 | Symrise Equal Weight | Barclays Capital | |
| 16.12.25 | Carl Zeiss Meditec Halten | DZ BANK | |
| 16.12.25 | Evonik Neutral | UBS AG | |
| 16.12.25 | adidas Outperform | Bernstein Research | |
| 15.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 15.12.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 15.12.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 12.12.25 | Carl Zeiss Meditec Neutral | UBS AG | |
| 12.12.25 | Brenntag Hold | Deutsche Bank AG | |
| 12.12.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 12.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 11.12.25 | Deutsche Börse Kaufen | DZ BANK | |
| 11.12.25 | Carl Zeiss Meditec Overweight | Barclays Capital | |
| 11.12.25 | Deutsche Börse Overweight | Barclays Capital | |
| 11.12.25 | Carl Zeiss Meditec Buy | Goldman Sachs Group Inc. | |
| 11.12.25 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 11.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 11.12.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 10.12.25 | Deutsche Börse Sector Perform | RBC Capital Markets |
HOT STOCKS DER LETZTEN 3 TAGE
| Brenntag | 5 |
| Sartorius vz. | 4 |
| Fresenius Medical Care | 3 |
| Merck | 2 |
| Henkel vz. | 2 |
| Evonik | 2 |
| freenet | 2 |
| adidas | 1 |
| Siemens Healthineers | 1 |
| Nemetschek | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.